REPORT ID 5247

Asia-Pacific Irritable Bowel Syndrome Treatment Market Report 2019

Publish Date
2019
Pages
103
Format
Electronic (PDF)

In this report, the Asia-Pacific Irritable Bowel Syndrome Treatment market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Irritable Bowel Syndrome Treatment for these regions, from   2019 to 2025 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Irritable Bowel Syndrome Treatment market competition by top manufacturers/players, with Irritable Bowel Syndrome Treatment sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Abbott Laboratories
    Synergy Pharmaceuticals, Inc.
    Sucampo Pharmaceuticals, Inc.
    Valeant Pharmaceuticals International, Inc.
    Ardelyx, Inc.
    Astellas Pharma Inc.
    Novartis AG
    GlaxoSmithKline plc.
    Ironwood Pharmaceuticals, Inc.

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Lubiprostone
    Linaclotide
    Eluxadoline
    Rifaximin
    Ramosetron Hydrochloride
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinic
    Home Care

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Irritable Bowel Syndrome Treatment Market  Report 2019
1 Irritable Bowel Syndrome Treatment Overview
    1.1 Product Overview and Scope of Irritable Bowel Syndrome Treatment
    1.2 Classification of Irritable Bowel Syndrome Treatment by Product Category
        1.2.1 Asia-Pacific Irritable Bowel Syndrome Treatment Market Size (Sales) Comparison by Types ( 2014-2024)
        1.2.2 Asia-Pacific Irritable Bowel Syndrome Treatment Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 Lubiprostone
        1.2.4 Linaclotide
        1.2.5 Eluxadoline
        1.2.6 Rifaximin
        1.2.7 Ramosetron Hydrochloride
        1.2.8 Others
    1.3 Asia-Pacific Irritable Bowel Syndrome Treatment Market by Application/End Users
        1.3.1 Asia-Pacific Irritable Bowel Syndrome Treatment Sales (Volume) and Market Share Comparison by Applications ( 2014-2024)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Home Care
    1.4 Asia-Pacific Irritable Bowel Syndrome Treatment Market by Region
        1.4.1 Asia-Pacific Irritable Bowel Syndrome Treatment Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 China Status and Prospect ( 2014-2024)
        1.4.3 Japan Status and Prospect ( 2014-2024)
        1.4.4 South Korea Status and Prospect ( 2014-2024)
        1.4.5 Taiwan Status and Prospect ( 2014-2024)
        1.4.6 India Status and Prospect ( 2014-2024)
        1.4.7 Southeast Asia Status and Prospect ( 2014-2024)
        1.4.8 Australia Status and Prospect ( 2014-2024)
    1.5 Asia-Pacific Market Size (Value and Volume) of Irritable Bowel Syndrome Treatment ( 2014-2024)
        1.5.1 Asia-Pacific Irritable Bowel Syndrome Treatment Sales and Growth Rate ( 2014-2024)
        1.5.2 Asia-Pacific Irritable Bowel Syndrome Treatment Revenue and Growth Rate ( 2014-2024)

2 Asia-Pacific Irritable Bowel Syndrome Treatment Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Irritable Bowel Syndrome Treatment Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Irritable Bowel Syndrome Treatment Sales Volume and Market Share of Key Players/Suppliers ( 2014-2019)
        2.1.2 Asia-Pacific Irritable Bowel Syndrome Treatment Revenue and Share by Players/Suppliers ( 2014-2019)
    2.2 Asia-Pacific Irritable Bowel Syndrome Treatment (Volume and Value) by Type
        2.2.1 Asia-Pacific Irritable Bowel Syndrome Treatment Sales and Market Share by Type ( 2014-2019)
        2.2.2 Asia-Pacific Irritable Bowel Syndrome Treatment Revenue and Market Share by Type ( 2014-2019)
    2.3 Asia-Pacific Irritable Bowel Syndrome Treatment (Volume) by Application
    2.4 Asia-Pacific Irritable Bowel Syndrome Treatment (Volume and Value) by Region
        2.4.1 Asia-Pacific Irritable Bowel Syndrome Treatment Sales and Market Share by Region ( 2014-2019)
        2.4.2 Asia-Pacific Irritable Bowel Syndrome Treatment Revenue and Market Share by Region ( 2014-2019)

3 China Irritable Bowel Syndrome Treatment (Volume, Value and Sales Price)
    3.1 China Irritable Bowel Syndrome Treatment Sales and Value ( 2014-2019)
        3.1.1 China Irritable Bowel Syndrome Treatment Sales Volume and Growth Rate ( 2014-2019)
        3.1.2 China Irritable Bowel Syndrome Treatment Revenue and Growth Rate ( 2014-2019)
        3.1.3 China Irritable Bowel Syndrome Treatment Sales Price Trend ( 2014-2019)
    3.2 China Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Type
    3.3 China Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Application

4 Japan Irritable Bowel Syndrome Treatment (Volume, Value and Sales Price)
    4.1 Japan Irritable Bowel Syndrome Treatment Sales and Value ( 2014-2019)
        4.1.1 Japan Irritable Bowel Syndrome Treatment Sales Volume and Growth Rate ( 2014-2019)
        4.1.2 Japan Irritable Bowel Syndrome Treatment Revenue and Growth Rate ( 2014-2019)
        4.1.3 Japan Irritable Bowel Syndrome Treatment Sales Price Trend ( 2014-2019)
    4.2 Japan Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Type
    4.3 Japan Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Application

5 South Korea Irritable Bowel Syndrome Treatment (Volume, Value and Sales Price)
    5.1 South Korea Irritable Bowel Syndrome Treatment Sales and Value ( 2014-2019)
        5.1.1 South Korea Irritable Bowel Syndrome Treatment Sales Volume and Growth Rate ( 2014-2019)
        5.1.2 South Korea Irritable Bowel Syndrome Treatment Revenue and Growth Rate ( 2014-2019)
        5.1.3 South Korea Irritable Bowel Syndrome Treatment Sales Price Trend ( 2014-2019)
    5.2 South Korea Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Type
    5.3 South Korea Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Application

6 Taiwan Irritable Bowel Syndrome Treatment (Volume, Value and Sales Price)
    6.1 Taiwan Irritable Bowel Syndrome Treatment Sales and Value ( 2014-2019)
        6.1.1 Taiwan Irritable Bowel Syndrome Treatment Sales Volume and Growth Rate ( 2014-2019)
        6.1.2 Taiwan Irritable Bowel Syndrome Treatment Revenue and Growth Rate ( 2014-2019)
        6.1.3 Taiwan Irritable Bowel Syndrome Treatment Sales Price Trend ( 2014-2019)
    6.2 Taiwan Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Type
    6.3 Taiwan Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Application

7 India Irritable Bowel Syndrome Treatment (Volume, Value and Sales Price)
    7.1 India Irritable Bowel Syndrome Treatment Sales and Value ( 2014-2019)
        7.1.1 India Irritable Bowel Syndrome Treatment Sales Volume and Growth Rate ( 2014-2019)
        7.1.2 India Irritable Bowel Syndrome Treatment Revenue and Growth Rate ( 2014-2019)
        7.1.3 India Irritable Bowel Syndrome Treatment Sales Price Trend ( 2014-2019)
    7.2 India Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Type
    7.3 India Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Application

8 Southeast Asia Irritable Bowel Syndrome Treatment (Volume, Value and Sales Price)
    8.1 Southeast Asia Irritable Bowel Syndrome Treatment Sales and Value ( 2014-2019)
        8.1.1 Southeast Asia Irritable Bowel Syndrome Treatment Sales Volume and Growth Rate ( 2014-2019)
        8.1.2 Southeast Asia Irritable Bowel Syndrome Treatment Revenue and Growth Rate ( 2014-2019)
        8.1.3 Southeast Asia Irritable Bowel Syndrome Treatment Sales Price Trend ( 2014-2019)
    8.2 Southeast Asia Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Type
    8.3 Southeast Asia Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Application

9 Australia Irritable Bowel Syndrome Treatment (Volume, Value and Sales Price)
    9.1 Australia Irritable Bowel Syndrome Treatment Sales and Value ( 2014-2019)
        9.1.1 Australia Irritable Bowel Syndrome Treatment Sales Volume and Growth Rate ( 2014-2019)
        9.1.2 Australia Irritable Bowel Syndrome Treatment Revenue and Growth Rate ( 2014-2019)
        9.1.3 Australia Irritable Bowel Syndrome Treatment Sales Price Trend ( 2014-2019)
    9.2 Australia Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Type
    9.3 Australia Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Application

10 Asia-Pacific Irritable Bowel Syndrome Treatment Players/Suppliers Profiles and Sales Data
    10.1 Abbott Laboratories
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Abbott Laboratories Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.1.4 Main Business/Business Overview
    10.2 Synergy Pharmaceuticals, Inc.
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Synergy Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.2.4 Main Business/Business Overview
    10.3 Sucampo Pharmaceuticals, Inc.
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Sucampo Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.3.4 Main Business/Business Overview
    10.4 Valeant Pharmaceuticals International, Inc.
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Valeant Pharmaceuticals International, Inc. Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.4.4 Main Business/Business Overview
    10.5 Ardelyx, Inc.
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Ardelyx, Inc. Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.5.4 Main Business/Business Overview
    10.6 Astellas Pharma Inc.
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Astellas Pharma Inc. Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.6.4 Main Business/Business Overview
    10.7 Novartis AG
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Novartis AG Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.7.4 Main Business/Business Overview
    10.8 GlaxoSmithKline plc.
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 GlaxoSmithKline plc. Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.8.4 Main Business/Business Overview
    10.9 Ironwood Pharmaceuticals, Inc.
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Ironwood Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.9.4 Main Business/Business Overview

11 Irritable Bowel Syndrome Treatment Manufacturing Cost Analysis
    11.1 Irritable Bowel Syndrome Treatment Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Irritable Bowel Syndrome Treatment

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Irritable Bowel Syndrome Treatment Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Irritable Bowel Syndrome Treatment Major Manufacturers  in 2018
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Irritable Bowel Syndrome Treatment Market Forecast ( 2019-2025)
    15.1 Asia-Pacific Irritable Bowel Syndrome Treatment Sales Volume, Revenue and Price Forecast ( 2019-2025)
        15.1.1 Asia-Pacific Irritable Bowel Syndrome Treatment Sales Volume and Growth Rate Forecast ( 2019-2025)
        15.1.2 Asia-Pacific Irritable Bowel Syndrome Treatment Revenue and Growth Rate Forecast ( 2019-2025)
        15.1.3 Asia-Pacific Irritable Bowel Syndrome Treatment Price and Trend Forecast ( 2019-2025)
    15.2 Asia-Pacific Irritable Bowel Syndrome Treatment Sales Volume, Revenue and Growth Rate Forecast by Region ( 2019-2025)
        15.2.1 Asia-Pacific Irritable Bowel Syndrome Treatment Sales Volume and Growth Rate Forecast by Region ( 2019-2025)
        15.2.2 Asia-Pacific Irritable Bowel Syndrome Treatment Revenue and Growth Rate Forecast by Region ( 2019-2025)
        15.2.3 China Irritable Bowel Syndrome Treatment Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.4 Japan Irritable Bowel Syndrome Treatment Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.5 South Korea Irritable Bowel Syndrome Treatment Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.6 Taiwan Irritable Bowel Syndrome Treatment Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.7 India Irritable Bowel Syndrome Treatment Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.8 Southeast Asia Irritable Bowel Syndrome Treatment Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.9 Australia Irritable Bowel Syndrome Treatment Sales, Revenue and Growth Rate Forecast ( 2019-2025)
    15.3 Asia-Pacific Irritable Bowel Syndrome Treatment Sales, Revenue and Price Forecast by Type ( 2019-2025)
        15.3.1 Asia-Pacific Irritable Bowel